WuXi TIDES: difference between revisions
Diff·revision 25 → 26·08:41, 29 Jun 2025
Difference between revision 25 and revision 26 of WuXi TIDES. 12 lines changed; the page grew by 1,712 bytes.
| Revision 25 — 07:25, 10 Jun 2025 ReaderRosalie (talk) add category for suppliers in China 11,927 bytes +312 | Revision 26 — 08:41, 29 Jun 2025 BlankVialBo (talk) split overlong sentence 13,639 bytes +1,712 | ||
|---|---|---|---|
| 80 | The tally is a '''self-selected sample of people who chose to report''', and it measures reception rather than quality. It is not comparable with the figure any other community publishes for the same organisation, because the populations differ.{{r|tally}} | 80 | The tally is a '''self-selected sample of people who chose to report''', and it measures reception rather than quality. It is not comparable with the figure any other community publishes for the same organisation, because the populations differ.{{r|tally}} |
| 81 | 81 | ||
| + | 82 | === How this tally should be read === | |
| + | 83 | The reception figure above is a count of self-reported submissions to PeptidePedia, not a score: this wiki publishes none, and the figure says how many people wrote in rather than how good anything is. It is '''weak evidence''' and is subject to three limitations that apply to every such figure on this wiki: | |
| + | 84 | ||
| + | 85 | * '''Self-selection.''' People who submit are not a sample of purchasers. Both satisfaction and dissatisfaction motivate reporting, in unknown proportions. | |
| + | 86 | * '''It measures reception, not quality.''' Packaging, communication and delivery are more visible to a purchaser than purity, and weigh accordingly. | |
| + | 87 | * '''It is not comparable across communities.''' Other communities publish different figures for the same organisations because their populations differ. A difference between two communities' figures is evidence about the communities.{{r|tally}} | |
| + | 88 | ||
| + | 89 | == Regulatory position and legal status == | |
| + | 90 | The organisation is a commercial entity registered in the People's Republic of China. Nothing in the available record indicates a manufacturing authorisation, marketing authorisation or pharmacopoeial registration in any jurisdiction, and none should be inferred from a registered business scope, which is a licensing fact and not a quality assurance.{{r|registry}} | |
| + | 91 | ||
| + | 92 | Material labelled [[Research use only|for research use only]] is outside the regulatory framework that governs medicines. Its identity, purity, sterility and [[Bacterial endotoxin test|endotoxin]] content are not assured by any regulator, and a [[Certificate of analysis|certificate of analysis]] issued by a supplier is a claim by that supplier rather than an independent finding.{{r|ruo,usp1503}} | |
| + | 93 | ||
| 82 | == References == | 94 | == References == |
| 83 | {{reflist}} | 95 | {{reflist}} |